January 22, 2018 / 12:05 PM / Updated 6 minutes ago BRIEF-Uniqure Receives Orphan Medicinal Product Designation In Europe For Amt-130 In Huntington’S Disease Reuters Staff 1 Min Read 
Uniqure Nv: 
* UNIQURE RECEIVES ORPHAN MEDICINAL PRODUCT DESIGNATION IN EUROPE FOR AMT-130 IN HUNTINGTON’S DISEASE Source text for Eikon: Further company coverage: